Vitamin D
[Vitamin D]
EPTIS Ringversuch Nr. 1616341 | Letze Änderung 2026-09-24 | URL: https://www.eptis.bam.de/pts1616341 https://www.eptis.bam.de/pts1616341
| Name des Anbieters | ||||||||||||||||
| Name des Anbieters | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | |||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||
| Sprache(n) | English | |||||||||||||||
| Anmerkungen | Provides EQA coverage and analytical assessment using endogenous material for Vitamin D. The Scheme covers the analytical working range but does focus at the clinically important lower concentrations. The Target Value is the Mass Spectrometry method mean, but this is validated annually by analyses of a number of pools by a reference method at CDC in Atlanta. | |||||||||||||||
| Klassifizierung | ||||||||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||
| Technische Einzelheiten | ||||||||||||||||
|
||||||||||||||||
| Ringversuchsziele | ||||||||||||||||
| Zielgruppe des Ringversuchs | Clinical Chemistry Public & Private Labs | |||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ISO/IEC 17043:2023 | |||||||||||||||
| Weitere Ziele | Post market surveillance of testing methods | |||||||||||||||
| Teilnehmerzahl | ||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043:2023 |
|||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||
| Kosten | ||||||||||||||||
| Teilnahmegebühr | Contact provider for current fee, which depends on location and extent of service required. | |||||||||||||||
| Regelmässig durchgeführt | Ja (Monthly (11 per year)) | |||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2017 | |||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Telefon: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Telefon: +44 121 414 7300 Fax: E-Mail: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
|||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.